Close Menu

NEW YORK — Barclays on Tuesday initiated coverage of Danaher, Ortho Clinical Diagnostics, and Thermo Fisher Scientific with Overweight ratings. The investment bank set a price target for Danaher at $260, Ortho at $25, and Thermo Fisher at $525.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.